[go: up one dir, main page]

AU2001274309A1 - Phosphoglycan messengers and their medical uses - Google Patents

Phosphoglycan messengers and their medical uses

Info

Publication number
AU2001274309A1
AU2001274309A1 AU2001274309A AU7430901A AU2001274309A1 AU 2001274309 A1 AU2001274309 A1 AU 2001274309A1 AU 2001274309 A AU2001274309 A AU 2001274309A AU 7430901 A AU7430901 A AU 7430901A AU 2001274309 A1 AU2001274309 A1 AU 2001274309A1
Authority
AU
Australia
Prior art keywords
medical uses
phosphoglycan
messengers
phosphoglycan messengers
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274309A
Inventor
Khalid Elased
Khalid Gumaa
Thomas Rademacher
Hassan Rahmoune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rodaris Pharmaceuticals Ltd
Original Assignee
Rodaris Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rodaris Pharmaceuticals Ltd filed Critical Rodaris Pharmaceuticals Ltd
Publication of AU2001274309A1 publication Critical patent/AU2001274309A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001274309A 2000-06-26 2001-06-21 Phosphoglycan messengers and their medical uses Abandoned AU2001274309A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0015627.3A GB0015627D0 (en) 2000-06-26 2000-06-26 Phosphoglycan messengers and their medical uses
GB0015627 2000-06-26
PCT/GB2001/002763 WO2002000673A1 (en) 2000-06-26 2001-06-21 Phosphoglycan messengers and their medical uses

Publications (1)

Publication Number Publication Date
AU2001274309A1 true AU2001274309A1 (en) 2002-01-08

Family

ID=9894421

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274309A Abandoned AU2001274309A1 (en) 2000-06-26 2001-06-21 Phosphoglycan messengers and their medical uses

Country Status (5)

Country Link
EP (1) EP1337538A1 (en)
AU (1) AU2001274309A1 (en)
CA (1) CA2427742A1 (en)
GB (1) GB0015627D0 (en)
WO (1) WO2002000673A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312662B1 (en) 1998-03-06 2001-11-06 Metabasis Therapeutics, Inc. Prodrugs phosphorus-containing compounds
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
KR100854851B1 (en) * 2000-07-06 2008-08-27 메타베이시스 테라퓨틱스, 인크. Combination of FFP inhibitors and antidiabetics, useful for treating diabetes
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2015123352A1 (en) 2014-02-13 2015-08-20 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
US9994600B2 (en) 2014-07-02 2018-06-12 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839466A (en) * 1986-04-11 1989-06-13 The Rockefeller University Insulin activity messengers
US6093697A (en) * 1994-11-07 2000-07-25 The University Of Virginia Patent Foundation Synthetic insulin mimetic substances
GB9618929D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate glycogen metabolism
DE19649350A1 (en) * 1996-11-28 1998-06-04 Hoechst Ag Inositol glycans with an insulin-like effect
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same

Also Published As

Publication number Publication date
WO2002000673A1 (en) 2002-01-03
CA2427742A1 (en) 2002-01-03
EP1337538A1 (en) 2003-08-27
GB0015627D0 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU3620600A (en) Skin-marking devices and their use
AU2002357643A1 (en) The human mob-5 (il-24) receptors and uses thereof
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2001261750A1 (en) Laminate and its use
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002343724A1 (en) Adhesive and use thereof
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2002227925A1 (en) Human beta-defensin-3
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
AU2001263492A1 (en) 21956 and 25856, human aminopeptidases and uses thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof